Generex Biotechnology Corporation Presented Positive Study Data At the American Diabetes Association Scientific Sessions

WORCESTER, Mass., June 9, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that data in respect of two of its products was presented at the American Diabetes Association's (ADA's) 69th Annual Scientific Sessions held in New Orleans June 5 - 9, 2009.

Back to news